Preview: Hot Topics in Primary Care: Diabetes Updates

In this video, Vivian Fonseca, MD, provides a preview of the session “Hot Topics in Primary Care: Diabetes Updates” at our Practical Updates in Primary Care 2023 Virtual Series, including updates to the American Diabetes Association Standards of Care in Diabetes­–2023 addressing population health, obesity management, and new available medications in the management of diabetes.

For more meeting coverage, visit the Practical Updates in Primary Care newsroom.

For more information about PUPC 2023 Virtual Series and to register for upcoming sessions, visit https://www.practicalupdates.consultant360.com/.

Vivian Fonseca, MD, is the Assistant Dean for Clinical Research and a professor of medicine at Tulane University (New Orleans, LA). 

TRANSCRIPTION:

Dr Vivian Fonseca: My name is Vivian Fonseca. I'm a professor of medicine and Assistant Dean for Clinical Research at Tulane University in New Orleans, Louisiana. I hope you're going to join us for this interesting program about a diabetes update that essentially updates us about the new 2023 American Diabetes Association guidelines for diabetes. It's called the Standards of Care. It's essentially not an annual thing anymore. It's a living live document that gets updated on their website on a regular basis, but it's published as a summary in diabetes care every January.

There are a few new things this year. Essentially, a focus on population health and how we can improve diabetes management across a large number of people. There's some discussion about obesity management integrated with diabetes and how we can utilize that not only to manage diabetes but maybe prevent diabetes, as well.

Then finally, there are always new ways of approaching the problem of diabetes, particularly focusing on some of the newer medications, when they should be used, such as in patients with congestive heart failure or chronic kidney disease or atherosclerotic cardiovascular disease. Finding the right medications for the right person, a sort of precision medicine approach.

With that, I think we will be able to come up with a plan to manage our patients better individually, as well as across the larger spectrum of people with diabetes in this country.